{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T00:26:49Z","timestamp":1717547209619},"reference-count":57,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.revmed.2024.05.016","type":"journal-article","created":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T11:52:57Z","timestamp":1716033177000},"page":"300-311","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Traduction et republication de\u00a0: \u00ab\u00a0Prise en charge de la maladie thromboembolique veineuse chez les patients atteints de tumeurs c\u00e9r\u00e9brales malignes\u00a0\u00bb"],"prefix":"10.1016","volume":"45","author":[{"given":"I.","family":"Mah\u00e9","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Fr\u00e8re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Pernod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.Id","family":"Baih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2024.05.016_bib0290","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.ejca.2012.10.021","article-title":"Incidence of venous throm- boembolism in patients with cancer\u00a0\u2013\u00a0a cohort study using linked United Kingdom databases","volume":"49","author":"Walker","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.revmed.2024.05.016_bib0295","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3171\/jns.2007.106.4.601","article-title":"Epidemiology of venous thromboembolism in 9489\u00a0patients with malignant glioma","volume":"106","author":"Semrad","year":"2007","journal-title":"J Neurosurg"},{"key":"10.1016\/j.revmed.2024.05.016_bib0300","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1111\/ene.15404","article-title":"Venous thromboembolic events in glioblastoma patients: an epidemiological study","volume":"29","author":"Eisele","year":"2022","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.revmed.2024.05.016_bib0305","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1182\/bloodadvances.2022008086","article-title":"ICH in primary or metastatic brain cancer patients with or without anticoagulant treatment: a systematic review and meta-analysis","volume":"6","author":"Giustozzi","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.revmed.2024.05.016_bib0310","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00415-012-6718-9","article-title":"A comprehensive analysis of vascular complications in 3,889\u00a0glioma patients from the German Glioma Network","volume":"260","author":"Seidel","year":"2013","journal-title":"J Neurol"},{"key":"10.1016\/j.revmed.2024.05.016_bib0315","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/B978-0-12-811161-1.00002-5","article-title":"Brain metastases: epidemiology","volume":"149","author":"Ostrom","year":"2018","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.revmed.2024.05.016_bib0320","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.hest.2022.01.005","article-title":"Hemorrhage in brain tumor\u00a0\u2013\u00a0an unresolved issue","volume":"3","author":"Ostrowski","year":"2022","journal-title":"Brain Hemorrhages"},{"key":"10.1016\/j.revmed.2024.05.016_bib0325","doi-asserted-by":"crossref","first-page":"e28069","DOI":"10.1097\/MD.0000000000028069","article-title":"Clinicoradiological features of brain metastases from thyroid cancer","volume":"100","author":"Kim","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.revmed.2024.05.016_bib0330","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.neuchi.2020.11.005","article-title":"Management of patients suffering from hemorrhagic intracranial metastases: propositions to help the neurosurgeon in emergency situations based on a literature review","volume":"67","author":"Boissonneau","year":"2021","journal-title":"Neurochirurgie"},{"key":"10.1016\/j.revmed.2024.05.016_bib0335","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/00005792-198501000-00002","article-title":"Cerebrovascular complications in patients with cancer","volume":"64","author":"Graus","year":"1985","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.revmed.2024.05.016_bib0340","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jocn.2008.05.010","article-title":"Prediction, clinical characteristics and prognosis of intracerebral hemorrhage in hepatocellular carcinoma patients with intracerebral metastasis","volume":"16","author":"Hsieh","year":"2009","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.revmed.2024.05.016_bib0345","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jocn.2020.08.006","article-title":"The primary sites leading to brain metastases: shifting trends at a tertiary care center","volume":"80","author":"Bhambhvani","year":"2020","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.revmed.2024.05.016_bib0350","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3390\/cancers15030619","article-title":"Associated factors of spontaneous hemorrhage in brain metastases in patients with lung adenocarcinoma","volume":"15","author":"Kim","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.revmed.2024.05.016_bib0355","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/jth.14007","article-title":"Clinically relevant bleeding in cancer patients treated for venous thromboem- bolism from the CATCH study","volume":"16","author":"Kamphuisen","year":"2018","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.revmed.2024.05.016_bib0360","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.thromres.2015.11.027","article-title":"Recurrent venous thromboembolism in glioblastoma","volume":"137","author":"Edwin","year":"2016","journal-title":"Thromb Res"},{"key":"10.1016\/j.revmed.2024.05.016_bib0365","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.rpth.2023.102172","article-title":"Acute venous thromboembolism in patients with brain cancer: clinical course","volume":"7","author":"Becattini","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.revmed.2024.05.016_bib0370","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1182\/blood-2015-02-626788","article-title":"Intracranial hemorrhage in patients with brain metastases treated with therapeutic enoxaparin: a matched cohort study","volume":"126","author":"Donato","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2024.05.016_bib0375","doi-asserted-by":"crossref","first-page":"e01638","DOI":"10.1002\/brb3.1638","article-title":"Risk of intracranial bleeding in patients with primary brain cancer receiving therapeutic anticoagulation for venous thromboembolism: a meta-analysis","volume":"10","author":"Porfidia","year":"2020","journal-title":"Brain Behav"},{"key":"10.1016\/j.revmed.2024.05.016_bib0380","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1634\/theoncologist.2014-0330","article-title":"Practical management of bevacizumab-related toxicities in glioblastoma","volume":"20","author":"Brandes","year":"2015","journal-title":"Oncologist"},{"key":"10.1016\/j.revmed.2024.05.016_bib0385","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1056\/NEJMoa1707358","article-title":"Lomustine and bevacizumab in progressive glioblastoma","volume":"377","author":"Wick","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2024.05.016_bib0390","doi-asserted-by":"crossref","first-page":"e236","DOI":"10.1016\/j.wneu.2019.06.043","article-title":"Risk of adverse vascular events in patients with malignant glioma treated with bevacizumab plus irinotecan: a systematic review and meta-analysis","volume":"130","author":"Dong","year":"2019","journal-title":"World Neurosurg"},{"key":"10.1016\/j.revmed.2024.05.016_bib0395","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJMoa1308345","article-title":"Bevacizumab plus radiotherapy\u00a0\u2013\u00a0temozolomide for newly diagnosed glioblastoma","volume":"370","author":"Chinot","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2024.05.016_bib0400","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1308573","article-title":"A randomized trial of bevacizumab for newly diagnosed glioblastoma","volume":"370","author":"Gilbert","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2024.05.016_bib0405","doi-asserted-by":"crossref","first-page":"15746","DOI":"10.1038\/srep15746","article-title":"Efficacy and safety of bevacizumab combined with chemotherapy for managing metastatic breast cancer: a meta-analysis of randomized controlled trials","volume":"5","author":"Li","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.revmed.2024.05.016_bib0410","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/phar.2310","article-title":"Bevacizumab use and the risk of arterial and venous thromboembolism in patients with high-grade gliomas: a nested case-control study","volume":"39","author":"Lee","year":"2019","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.revmed.2024.05.016_bib0415","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11060-011-0642-1","article-title":"Safety of concurrent bevacizumab therapy and anticoagulation in glioma patients","volume":"106","author":"Norden","year":"2012","journal-title":"J Neurooncol"},{"key":"10.1016\/j.revmed.2024.05.016_bib0420","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.3390\/cancers15153893","article-title":"Cancer- associated thrombosis on bevacizumab: risk of recurrence and bleeding when bevacizumab is stopped or continued","volume":"15","author":"Mayenga","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.revmed.2024.05.016_bib0425","doi-asserted-by":"crossref","first-page":"e18289","DOI":"10.1200\/JCO.2017.35.15_suppl.e18289","article-title":"Venous thromboembolism incidence in radiation oncology: retrospective trial","volume":"35","author":"Cherkashin","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.revmed.2024.05.016_bib0430","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1002\/cam4.4559","article-title":"Venous thromboembolism and radiation therapy: the final radiation-induced thrombosis study analysis","volume":"11","author":"Daguenet","year":"2022","journal-title":"Cancer Med"},{"key":"10.1016\/j.revmed.2024.05.016_bib0435","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.critrevonc.2017.03.006","article-title":"Venous thromboembolism in radiation therapy cancer patients: findings from the RIETE registry","volume":"113","author":"Guy","year":"2017","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.revmed.2024.05.016_bib0440","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1161\/STROKEAHA.113.003701","article-title":"Neuroimaging in intracerebral hemorrhage","volume":"45","author":"Macellari","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.revmed.2024.05.016_bib0445","doi-asserted-by":"crossref","first-page":"100599","DOI":"10.1016\/j.rpth.2023.100599","article-title":"OC 54.5\u00a0Association of inferior vena cava filter (IVCF) use and 30-day mortality and 180-day intracranial hemorrhage among patients with brain metastasis and venous thromboembolism: an updated analysis","volume":"7","author":"Abrahao","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.revmed.2024.05.016_bib0450","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1002\/onco.13584","article-title":"Treatment of cancer-associated venous thromboembolism with low-molecular-weight heparin or direct oral anticoagulants: patient selection, controversies, and caveats","volume":"26","author":"O\u2019Connell","year":"2021","journal-title":"Oncologist"},{"key":"10.1016\/j.revmed.2024.05.016_bib0455","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJMoa025313","article-title":"Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer","volume":"349","author":"Lee","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2024.05.016_bib0460","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/archinte.162.15.1729","article-title":"Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled study","volume":"162","author":"Meyer","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.revmed.2024.05.016_bib0465","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1056\/NEJMoa1711948","article-title":"Edoxaban for the treatment of cancer-associated venous thromboembolism","volume":"378","author":"Raskob","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2024.05.016_bib0470","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1200\/JCO.2018.78.8034","article-title":"Comparison of an oral factor Xa inhibitor with low molecular weight heparin in patients with cancer with venous thromboembolism: results of a randomized trial (SELECT-D)","volume":"36","author":"Young","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.revmed.2024.05.016_bib0475","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1056\/NEJMoa1915103","article-title":"Apixaban for the treatment of venous thromboembolism associated with cancer","volume":"382","author":"Agnelli","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2024.05.016_bib0480","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/jth.14662","article-title":"Apixaban and dalteparin in active malignancy-associated venous thromboembolism: the ADAM VTE trial","volume":"18","author":"McBane 2nd","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.revmed.2024.05.016_bib0485","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/jth.14336","article-title":"Intracranial hemorrhage with direct oral anticoagulants in patients with brain tumors","volume":"17","author":"Carney","year":"2019","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.revmed.2024.05.016_bib0490","doi-asserted-by":"crossref","first-page":"6291","DOI":"10.1182\/bloodadvances.2020003238","article-title":"Intracranial hemorrhage with direct oral anticoagulants in patients with brain metastases","volume":"4","author":"Leader","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.revmed.2024.05.016_bib0495","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.thromres.2021.10.023","article-title":"Direct oral anticoagulants or low-molecular-weight heparins for venous thromboembolism in patients with brain tumors","volume":"208","author":"Lee","year":"2021","journal-title":"Thromb Res"},{"key":"10.1016\/j.revmed.2024.05.016_bib0500","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/onco.13698","article-title":"Safety of direct oral anticoagulants in central nervous system malignancies","volume":"26","author":"Swartz","year":"2021","journal-title":"Oncologist"},{"key":"10.1016\/j.revmed.2024.05.016_bib0505","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s10143-021-01539-9","article-title":"Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma","volume":"45","author":"Dubinski","year":"2022","journal-title":"Neurosurg Rev"},{"key":"10.1016\/j.revmed.2024.05.016_bib0510","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1093\/neuonc\/noac125","article-title":"Risk of intracranial hemorrhage with direct oral anticoagulants vs low molecular weight heparin in glioblastoma: a retrospective cohort study","volume":"24","author":"Reed-Guy","year":"2022","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.revmed.2024.05.016_bib0515","doi-asserted-by":"crossref","first-page":"100611","DOI":"10.1016\/j.rpth.2023.100611","article-title":"OC 54.4\u00a0Multinational cohort analysis of intracranial hemorrhage outcomes in patients with brain tumors receiving anticoagulation (ABC study)","volume":"7","author":"Leader","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.revmed.2024.05.016_bib0520","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1182\/bloodadvances.2022009192","article-title":"DOACs in patients with brain cancers: promising but still a long way to go","volume":"7","author":"Giustozzi","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.revmed.2024.05.016_bib0525","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/bloodadvances.2022008846","article-title":"DOACs for VTE in patients with brain cancer and brain metastases: choices, choices, choices","volume":"7","author":"Buka","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.revmed.2024.05.016_bib0530","doi-asserted-by":"crossref","first-page":"101749","DOI":"10.1016\/j.rpth.2023.101749","article-title":"PB0938\u00a0Direct oral anticoagulants versus low molecular weight heparins in patients with brain tumor receiving therapeutic anticoagulation: a systematic review and meta-analysis","volume":"7","author":"Fr\u00e8re","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.revmed.2024.05.016_bib0535","doi-asserted-by":"crossref","first-page":"100594","DOI":"10.1016\/j.rpth.2023.100594","article-title":"OC 54.3\u00a0Direct oral anticoagulants vs low molecular weight heparin in the management of patients with primary or metastatic brain tumours: a systematic review and meta-analysis","volume":"7","author":"Yu","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.revmed.2024.05.016_bib0540","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.thromres.2023.04.009","article-title":"Effectiveness and safety of anticoagulants among venous thromboembolism cancer patients with and without brain cancer","volume":"226","author":"Cohen","year":"2023","journal-title":"Thromb Res"},{"key":"10.1016\/j.revmed.2024.05.016_bib0545","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.23.00294","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO guideline update","volume":"41","author":"Key","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.revmed.2024.05.016_bib0550","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1182\/bloodadvances.2020003442","article-title":"American Society of Hematology 2021\u00a0guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer","volume":"5","author":"Lyman","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.revmed.2024.05.016_bib0555","unstructured":"National Comprehensive Cancer Network. NCCN guidelines Version 2.2023. Cancer-associated venous thromboembolic disease. June 1, 2023\u00a0NCCN.org."},{"key":"10.1016\/j.revmed.2024.05.016_bib0560","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1016\/S1470-2045(22)00160-7","article-title":"2022\u00a0international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19","volume":"23","author":"Farge","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.revmed.2024.05.016_bib0565","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.annonc.2022.12.014","article-title":"Venous thromboembolism in cancer patients: ESMO clinical practice guideline","volume":"34","author":"Falanga","year":"2023","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.revmed.2024.05.016_bib0570","first-page":"19","article-title":"Anticoagulant treatment of cancer-associated thromboembolism","volume":"117","author":"Mah\u00e9","year":"2024","journal-title":"Arch Cardiovasc Dis"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866324005782?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866324005782?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T12:23:07Z","timestamp":1717503787000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866324005782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":57,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0248866324005782"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2024.05.016","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Traduction et republication de\u00a0: \u00ab\u00a0Prise en charge de la maladie thromboembolique veineuse chez les patients atteints de tumeurs c\u00e9r\u00e9brales malignes\u00a0\u00bb","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2024.05.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI).","name":"copyright","label":"Copyright"}]}}